Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Tirzepatide for Sale > Amphipathic Dual-Receptor Targeted Tirzepatide Lipid-Peptide Conjugate Laboratory Research Raw Material
Amphipathic Dual-Receptor  Targeted Tirzepatide Lipid-Peptide Conjugate Laboratory Research Raw Material buy - large image1
Amphipathic Dual-Receptor  Targeted Tirzepatide Lipid-Peptide Conjugate Laboratory Research Raw Material buy - image1
Amphipathic Dual-Receptor  Targeted Tirzepatide Lipid-Peptide Conjugate Laboratory Research Raw Material buy - image2
Amphipathic Dual-Receptor  Targeted Tirzepatide Lipid-Peptide Conjugate Laboratory Research Raw Material buy - image3
Amphipathic Dual-Receptor  Targeted Tirzepatide Lipid-Peptide Conjugate Laboratory Research Raw Material buy - image4
Amphipathic Dual-Receptor  Targeted Tirzepatide Lipid-Peptide Conjugate Laboratory Research Raw Material buy - image5
Amphipathic Dual-Receptor  Targeted Tirzepatide Lipid-Peptide Conjugate Laboratory Research Raw Material buy - image6

Amphipathic Dual-Receptor Targeted Tirzepatide Lipid-Peptide Conjugate Laboratory Research Raw Material

2100 Inquiries

Unit Price:

$29-31/BOU FOB

Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99.9%

Port:

GUANGZHOU

Brand:

BAND

Packaging:

5mg/1 vials 10vials/1 box

Price valid (until):

2027-05-01

Company Type:
Trader
Location:
Hongkong, China
Qualification:
Main Products:

Tirzepatide,Retatrutide,Semaglutide,GHK-Cu

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  



    If you're interested, just click "Contact supplier"
    Tirzepatide is a long-acting synthetic peptide that acts as a dual agonist of GIP and GLP-1 receptors. It is widely used in the research and development of drugs for type 2 diabetes, weight management, obesity and related metabolic disorders.

    Our factory produces Tirzepatide with advanced synthesis and purification technology, with stable process and strict quality control. The product has high purity, low impurities, good stability and reliable performance, which can meet the needs of laboratory research, pharmaceutical development and industrial production.
    Items Specifications
    CAS NO. 
    2023788-19-2
    Product name Tirzepatide
    Purity 99.9%
    Packaging 5mg/vials 10 vials/box
    Payment term paypal ,bitcoin, usdt, usdc, alipay, bank transfer
    MOQ 10 vials
    Shelf life 2 years
    Certificate COA


    Product Introduction

    Tirzepatide is a synthetic polypeptide compound prepared through mature solid-phase peptide synthesis and multi-step purification techniques. It is structured to interact with specific biological receptors, serving as a professional research tool for exploring ligand-receptor binding characteristics and intracellular signal transmission rules.


    This product is widely adopted by life science labs, biotechnology enterprises and academic research teams around the world. Researchers can apply it to carry out a series of basic studies focusing on peptide properties, receptor interaction modes and related biochemical reaction mechanisms under strictly controlled laboratory environments.


    Each production batch is implemented with full-process quality supervision and strict sampling inspection. All test records are complete to guarantee stable chemical structure and consistent performance of the product. This material is limited to in vitro laboratory experiments and academic research only. It is not designed for any form of body contact, intake or non-research scenarios. No descriptions beyond the attributes of laboratory research materials are involved.

    Shop High Quality Tirzepatide Raw Material for Research Use Only-Detailed Image 1
    Shop High Quality Tirzepatide Raw Material for Research Use Only-Detailed Image 2
    Shop High Quality Tirzepatide Raw Material for Research Use Only-Detailed Image 3


    Shop High Quality Tirzepatide Raw Material for Research Use Only-Detailed Image 4


    Key Product Advantages


    1. Ultra-High Purity & Quality Assurance: Purity ≥99.0% verified by HPLC, with complete COA, HPLC, NMR, MS and other quality inspection reports provided, ensuring product quality meets international pharmaceutical raw material standards.

    2. Stable Production Process: Mature synthesis and lyophilization process, stable product properties, not easy to degrade, convenient for storage and long-distance transportation.

    3. Factory Direct Supply: Independent production base, sufficient inventory, fast and stable delivery, supporting small-batch trial orders and large-scale bulk wholesale.

    4. Flexible Customization: Support customized packaging specifications and personalized labeling services to meet diverse procurement needs of customers.

    5. Strict Quality Control: Full monitoring from raw material screening to finished product delivery, eliminating quality risks and ensuring product safety and reliability.
      
    Shop High Quality Tirzepatide Raw Material for Research Use Only-Detailed Image 5
    Shop High Quality Tirzepatide Raw Material for Research Use Only-Detailed Image 6
    Shop High Quality Tirzepatide Raw Material for Research Use Only-Detailed Image 7
    Shop High Quality Tirzepatide Raw Material for Research Use Only-Detailed Image 8
    Shop High Quality Tirzepatide Raw Material for Research Use Only-Detailed Image 9
    Shop High Quality Tirzepatide Raw Material for Research Use Only-Detailed Image 10
    Shop High Quality Tirzepatide Raw Material for Research Use Only-Detailed Image 11


      Product Advantages  


    Ultra-high Purity and Structural Stability
    Adopting advanced synthesis and chromatographic purification technologies. The product purity is maintained above 99%. Multiple professional testing methods are used to verify molecular structure and composition, effectively ensuring stable performance and highly repeatable experimental data in various research tests.


    Excellent Solubility and Easy Operation
    The freeze-drying process fully retains the inherent chemical properties of the polypeptide. The powder dissolves quickly in common aqueous solvents. It is convenient to prepare stock solutions and working solutions, which adapts to diverse operational requirements of daily laboratory experiments.


    Targeted Properties for Professional Research
    With optimized molecular design, this polypeptide features definite binding characteristics with specific receptors. It is highly applicable to in-depth research on receptor recognition, signal cascade reactions and related biochemical networks, providing reliable raw materials for specialized peptide research projects.


    Complete Quality Traceability System
    Complete certification documents including Certificate of Analysis, HPLC reports and mass spectrometry test data can be provided upon request. The whole production process follows standardized specifications for laboratory supplies, meeting the quality access standards of research organizations in different regions.


    Long Storage Period and Low Degradation Rate
    The special freeze-dried form and sealed packaging greatly slow down material degradation. When stored in accordance with requirements, the product can keep stable for 24 months. Reconstituted solution also maintains good activity within the valid period, fully supporting medium and long-term research work.

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Polypeptide

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,Semaglutide,GHK-Cu

    Location:

    RM 701, UNIT 108, 7/F, TWR B NEW MANDARIN PLAZA 14 SCIENCE MUSEUM RD TSIM SHA TSUI HONG KONG

    Year of Establishment:

    2026

  • Inquiry History
    2100 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Tirzepatide

    20 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    United States

    tirzepatide

    30 MG Oct 20, 2026
    United States

    Tirzepatide

    50 MG Oct 20, 2026
    Spain

    tirzepatide

    20 MG Oct 19, 2026
    United States

    tirzepatide

    30 MG Oct 19, 2026
    Philippines

    tirzepatide

    40 MG Oct 19, 2026
    United States

    tirzepatide

    50 MG Oct 19, 2026
    United States

    tirzepatide

    50 MG Oct 19, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.